← Leaderboards
Chen-Pin Wang
University Of Texas Hlth Science Center
$721,019
Attributed
$878,722
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $162.6K · FY2006–13$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$878,722 · 2
By mechanism
K25$563,315 · 1
R21$315,407 · 1
Top collaborators
- Donna M Lehman2 shared
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Thomas W Oates$5,508,659
- Donna M Lehman$8,191,069
- Yves Claude Gorin$1,843,830
- Farook Thameem$554,010
- Javier Hernandez$620,108
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignCohortHeterogeneityTheoriesIncidenceDyslipidemiasDiabetes MellitusGlycosylated Hemoglobin ALipidsResponsePharmaceutical PreparationsMediatingHyperglycemiaGlucoseAffectBody Mass IndexBlood VesselsDemographicsBlood PressureCharacteristicsBlood Glucose RegulationControl GroupsBehaviorCareer
Grant awards (7)
Metformin, Statins, and Prostate Cancer Prevention in Type 2 Diabetes$152,826
R21 · FY2013 · CA · contact PI
Metformin, Statins, and Prostate Cancer Prevention in Type 2 Diabetes$162,581
R21 · FY2012 · CA · contact PI
Heterogeneity, Glycemic Control & Macro-Vascular Complications in Type 2 Diabetes$114,254
K25 · FY2010 · DK · contact PI
Heterogeneity, Glycemic Control & Macro-Vascular Complications in Type 2 Diabetes$108,419
K25 · FY2009 · DK · contact PI
Heterogeneity, Glycemic Control & Macro-Vascular Complications in Type 2 Diabetes$114,037
K25 · FY2008 · DK · contact PI
Heterogeneity, Glycemic Control & Macro-Vascular Complications in Type 2 Diabetes$109,484
K25 · FY2007 · DK · contact PI
Heterogeneity, Glycemic Control & Macro-Vascular Complications in Type 2 Diabetes$117,121
K25 · FY2006 · DK · contact PI